More than three decades ago, Congress created the 340B program to help safety-net hospitals and clinics expand resources and care for underserved communities. By requiring pharmaceutical companies to ...
This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of ...
WASHINGTON - A Senate health committee met last week to scrutinize the 340B Program, an initiative intended to foster the ...
AHA writes to express our strong support for this vital program that allows eligible hospitals to maintain, improve and expand access to essential services and medications for the patients and ...
On July 31, the US Department of Health and Human Services’ (HHS) Health Resources and Services Administration (HRSA) announced the availability of a new pilot program altering how pharmaceutical ...
The Health Resources and Services Administration ("HRSA") plans to implement a limited pilot program that will allow approved manufacturers to issue post-purchase rebates for 340B covered outpatient ...
A recent proposal from the Trump administration aims to hasten the recovery of $7.8 billion in improper reimbursements for discounted drugs under the 340B program. This initiative, hidden within a ...